Evolocumab in Acute Coronary Syndrome

NCT03515304 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Evolocumab
DRUG: Placebo

Sponsor

Johns Hopkins University

Collaborators

[object Object]